Savara, Inc. (SVRA)
5.565
-0.02
(-0.45%)
USD |
NASDAQ |
Aug 24, 16:00
5.565
0.00 (0.00%)
After-Hours: 19:20
Savara Market Cap : 1.143B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.148B |
| August 20, 2026 | 1.128B |
| August 19, 2026 | 1.146B |
| August 18, 2026 | 1.103B |
| August 17, 2026 | 1.103B |
| August 14, 2026 | 1.105B |
| August 13, 2026 | 1.082B |
| August 12, 2026 | 1.171B |
| August 11, 2026 | 1.144B |
| August 10, 2026 | 1.177B |
| August 07, 2026 | 1.197B |
| August 06, 2026 | 1.189B |
| August 05, 2026 | 1.129B |
| August 04, 2026 | 1.109B |
| August 03, 2026 | 1.092B |
| July 31, 2026 | 1.119B |
| July 30, 2026 | 1.135B |
| July 29, 2026 | 1.082B |
| July 28, 2026 | 1.092B |
| July 27, 2026 | 1.113B |
| July 24, 2026 | 1.129B |
| July 23, 2026 | 1.178B |
| July 22, 2026 | 1.158B |
| July 21, 2026 | 1.197B |
| July 20, 2026 | 1.125B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.131B |
| July 16, 2026 | 1.131B |
| July 15, 2026 | 1.191B |
| July 14, 2026 | 1.166B |
| July 13, 2026 | 1.176B |
| July 10, 2026 | 1.236B |
| July 09, 2026 | 1.289B |
| July 08, 2026 | 1.307B |
| July 07, 2026 | 1.273B |
| July 06, 2026 | 1.271B |
| July 02, 2026 | 1.275B |
| July 01, 2026 | 1.242B |
| June 30, 2026 | 1.262B |
| June 29, 2026 | 1.236B |
| June 26, 2026 | 1.209B |
| June 25, 2026 | 1.236B |
| June 24, 2026 | 1.195B |
| June 23, 2026 | 1.184B |
| June 22, 2026 | 1.166B |
| June 18, 2026 | 1.127B |
| June 17, 2026 | 1.102B |
| June 16, 2026 | 1.086B |
| June 15, 2026 | 1.092B |
| June 12, 2026 | 1.078B |
| June 11, 2026 | 1.080B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 182.13B |
| Insmed, Inc. | 27.07B |
| United Therapeutics Corp. | 21.89B |
| Vertex Pharmaceuticals, Inc. | 138.77B |
| SELLAS Life Sciences Group, Inc. | 2.892B |
Market Cap Related Metrics
| PEG Ratio | -0.7785 |
| Price to Book Value | 7.957 |
| Price | 5.565 |
| Earnings Yield | -10.36% |
| PEGY Ratio | -0.7785 |